  | 
|  May 26, 2004 Study Shows Patients Treated with Avelox® (moxifloxacin HCl) Recovered Faster from Flare-Ups of Chronic Bronchitis than Patients Treated with Commonly Prescribed Antibiotics
May 19, 2004 FDA Approves Avelox® (moxifloxacin HCl) for Community Acquired Pneumonia Due to Multi-Drug Resistant Streptococcus Pneumoniae
May 4, 2004 Treatment With Avelox® (moxifloxacin HCl) Leads To Faster Symptom Improvement And Earlier Hospital Discharge For Pneumonia Patients
May 4, 2004 New Surveillance Data Shows Avelox® (moxifloxacin HCl) Remains Active Against Bacterial Strains Compared To Other Fluoroquinolone Antibiotics
March 9, 2004 Recently Published Study Shows Antibiotic Provides Excellent Clinical Results for Millions of Patients with Acute Exacerbations of Chronic Bronchitis (AECB)
See Your Healthcare Provider Remember, your healthcare provider is the best source of information regarding you and your health. The information provided on this Web site is for educational purposes only and is not intended to replace individualized medical advice or discussions with a healthcare professional. | *AVELOX is approved for use in the treatment of: Acute Bacterial Exacerbation of Chronic Bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Staphylococcus aureus, or Moraxella catarrhalis;
Acute Bacterial Sinusitis caused by Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis; Community-acquired Pneumonia caused by Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, Klebsiella pneumoniae, Mycoplasma pneumoniae, or Chlamydia pneumoniae; and Uncomplicated Skin and Skin Structure Infections caused by Staphylococcus aureus or Streptococcus pyogenes.
†Tissue/fluid penetration is regarded as essential to therapeutic efficacy, but penetration levels have not been correlated with in vivo results.
Important Safety Considerations AVELOX is a prescription medication that is generally well tolerated. The most common side effects, which are usually mild, include nausea, diarrhea, and dizziness. You should be careful about driving or operating machinery until you are sure AVELOX is not causing dizziness.
You should not take AVELOX if you have ever had an allergic reaction to AVELOX or any of the other group of antibiotics known as "quinolones," such as ciprofloxacin or levofloxacin. You should avoid taking AVELOX if you have been diagnosed with an abnormal heartbeat such as an arrhythmia or are using certain medications used to treat an abnormal heartbeat. These include quinidine, procainamide, amiodarone, and sotalol.
If you are pregnant or planning to become pregnant while taking AVELOX, talk to your healthcare provider before taking this medication. AVELOX is not recommended for use during pregnancy or nursing, as the effects on the unborn child or nursing infant are unknown.
AVELOX is not recommended for children under the age of 18 years.
Many antacids and multivitamins may interfere with the absorption of AVELOX and may prevent it from working properly. You should take AVELOX either 4 hours before or 8 hours after taking these products.
Be sure to inform your healthcare provider of any medical conditions you have and all prescription and non-prescription medications or supplements you are taking. If you have any concerns about your medication or side effects, please contact your healthcare provider. He or she has been provided with complete prescribing information for AVELOX.
Please click here for additional Patient Information regarding AVELOX.
New to the Site | Feedback | Contact Webmaster
© 2002 Bayer Corporation. Site development provided by H2.
| |